0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Orally Disintegrating Tablet Market Research Report 2026
Published Date: 2026-02-26
|
Report Code: QYRE-Auto-14V9021
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Orally Disintegrating Tablet Market Outlook 2022
BUY CHAPTERS

Global Orally Disintegrating Tablet Market Research Report 2026

Code: QYRE-Auto-14V9021
Report
2026-02-26
Pages:133
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Orally Disintegrating Tablet Market Size

The global Orally Disintegrating Tablet market was valued at US$ 22810 million in 2025 and is anticipated to reach US$ 34650 million by 2032, at a CAGR of 6.2% from 2026 to 2032.

Orally Disintegrating Tablet Market

Orally Disintegrating Tablet Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Orally Disintegrating Tablet competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.In 2024, global orally disintegrating tablet production reached approximately 3570 m units, with an average global market price of around US$ 6 perunit.he average gross profit margin for this product is 62% and global capacity is about 4000 m units.
Market Drivers:
The global Orally Disintegrating Tablet (ODT) market is primarily driven by increasing demand for convenient and patient-friendly drug delivery systems. As the global aging population grows and more patients experience difficulty swallowing traditional tablets and capsules, ODTs provide an effective alternative. The pediatric segment also fuels growth due to the ease of administration and improved compliance. Additionally, advancements in formulation technologies, such as the use of superdisintegrants and taste-masking agents, have enhanced the efficacy and palatability of ODTs, encouraging pharmaceutical companies to develop more drugs in this format.
Market Challenges:
Despite strong demand, the ODT market faces several challenges. One major barrier is the complexity and higher cost of manufacturing ODTs compared to conventional tablets, especially in achieving quick disintegration and taste masking without compromising drug stability. Regulatory hurdles can also slow product approvals due to stringent quality standards. Moreover, not all active pharmaceutical ingredients (APIs) are suitable for ODT formulation due to factors like dose size, bitterness, or poor solubility, which limits the range of drugs that can be adapted into this format.
Market Trends:
The ODT market is witnessing a trend toward expansion into high-value therapeutic areas such as central nervous system disorders, cardiovascular diseases, and pain management. Additionally, there is increasing interest in combining ODTs with rapid-onset APIs for emergency-use treatments like migraines and seizures. Technological innovations in 3D printing and polymer-based film layering are also contributing to more customizable and faster-dissolving ODTs. As more generic and branded drug manufacturers recognize the commercial potential of this dosage form, the market is expected to grow steadily in both developed and emerging economies.
This report delivers a comprehensive overview of the global Orally Disintegrating Tablet market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Orally Disintegrating Tablet. The Orally Disintegrating Tablet market size, estimates, and forecasts are provided in terms of sales volume (M Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Orally Disintegrating Tablet market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Orally Disintegrating Tablet manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Orally Disintegrating Tablet Market Report

Report Metric Details
Report Name Orally Disintegrating Tablet Market
Accounted market size in 2025 US$ 22810 million
Forecasted market size in 2032 US$ 34650 million
CAGR 6.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Anti-Psychotics Drug
  • Anti-Epileptics Drug
  • Others
by Application
  • CNS Diseases
  • Gastrointestinal Diseases
  • CVS Diseases
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Teva, Merck, Viatris, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb, Conquer, Eisai, Cipla, Zydus Lifesciences, Qilu Pharma, Hisun Pharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Orally Disintegrating Tablet manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Orally Disintegrating Tablet sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Orally Disintegrating Tablet Market growing?

Ans: The Orally Disintegrating Tablet Market witnessing a CAGR of 6.2% during the forecast period 2026-2032.

What is the Orally Disintegrating Tablet Market size in 2032?

Ans: The Orally Disintegrating Tablet Market size in 2032 will be US$ 34650 million.

Who are the main players in the Orally Disintegrating Tablet Market report?

Ans: The main players in the Orally Disintegrating Tablet Market are Teva, Merck, Viatris, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb, Conquer, Eisai, Cipla, Zydus Lifesciences, Qilu Pharma, Hisun Pharm

What are the Application segmentation covered in the Orally Disintegrating Tablet Market report?

Ans: The Applications covered in the Orally Disintegrating Tablet Market report are CNS Diseases, Gastrointestinal Diseases, CVS Diseases, Others

What are the Type segmentation covered in the Orally Disintegrating Tablet Market report?

Ans: The Types covered in the Orally Disintegrating Tablet Market report are Anti-Psychotics Drug, Anti-Epileptics Drug, Others

1 Orally Disintegrating Tablet Market Overview
1.1 Product Definition
1.2 Orally Disintegrating Tablet by Type
1.2.1 Global Orally Disintegrating Tablet Market Value by Type: 2025 vs 2032
1.2.2 Anti-Psychotics Drug
1.2.3 Anti-Epileptics Drug
1.2.4 Others
1.3 Orally Disintegrating Tablet by Application
1.3.1 Global Orally Disintegrating Tablet Market Value by Application: 2025 vs 2032
1.3.2 CNS Diseases
1.3.3 Gastrointestinal Diseases
1.3.4 CVS Diseases
1.3.5 Others
1.4 Global Orally Disintegrating Tablet Market Size Estimates and Forecasts
1.4.1 Global Orally Disintegrating Tablet Revenue 2021–2032
1.4.2 Global Orally Disintegrating Tablet Sales 2021–2032
1.4.3 Global Orally Disintegrating Tablet Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Orally Disintegrating Tablet Market Competition by Manufacturers
2.1 Global Orally Disintegrating Tablet Sales Market Share by Manufacturers (2021–2026)
2.2 Global Orally Disintegrating Tablet Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Orally Disintegrating Tablet Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Orally Disintegrating Tablet, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Orally Disintegrating Tablet, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Orally Disintegrating Tablet, Product Types and Applications
2.7 Global Key Manufacturers of Orally Disintegrating Tablet, Date of Entry into the Industry
2.8 Global Orally Disintegrating Tablet Market Competitive Situation and Trends
2.8.1 Global Orally Disintegrating Tablet Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Orally Disintegrating Tablet Players Market Share by Revenue
2.8.3 Global Orally Disintegrating Tablet Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Orally Disintegrating Tablet Market Scenario by Region
3.1 Global Orally Disintegrating Tablet Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Orally Disintegrating Tablet Sales by Region: 2021–2032
3.2.1 Global Orally Disintegrating Tablet Sales by Region: 2021–2026
3.2.2 Global Orally Disintegrating Tablet Sales by Region: 2027–2032
3.3 Global Orally Disintegrating Tablet Revenue by Region: 2021–2032
3.3.1 Global Orally Disintegrating Tablet Revenue by Region: 2021–2026
3.3.2 Global Orally Disintegrating Tablet Revenue by Region: 2027–2032
3.4 North America Orally Disintegrating Tablet Market Facts & Figures by Country
3.4.1 North America Orally Disintegrating Tablet Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Orally Disintegrating Tablet Sales by Country (2021–2032)
3.4.3 North America Orally Disintegrating Tablet Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Orally Disintegrating Tablet Market Facts & Figures by Country
3.5.1 Europe Orally Disintegrating Tablet Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Orally Disintegrating Tablet Sales by Country (2021–2032)
3.5.3 Europe Orally Disintegrating Tablet Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Orally Disintegrating Tablet Market Facts & Figures by Region
3.6.1 Asia Pacific Orally Disintegrating Tablet Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Orally Disintegrating Tablet Sales by Region (2021–2032)
3.6.3 Asia Pacific Orally Disintegrating Tablet Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Orally Disintegrating Tablet Market Facts & Figures by Country
3.7.1 Latin America Orally Disintegrating Tablet Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Orally Disintegrating Tablet Sales by Country (2021–2032)
3.7.3 Latin America Orally Disintegrating Tablet Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Orally Disintegrating Tablet Market Facts & Figures by Country
3.8.1 Middle East and Africa Orally Disintegrating Tablet Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Orally Disintegrating Tablet Sales by Country (2021–2032)
3.8.3 Middle East and Africa Orally Disintegrating Tablet Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Orally Disintegrating Tablet Sales by Type (2021–2032)
4.1.1 Global Orally Disintegrating Tablet Sales by Type (2021–2026)
4.1.2 Global Orally Disintegrating Tablet Sales by Type (2027–2032)
4.1.3 Global Orally Disintegrating Tablet Sales Market Share by Type (2021–2032)
4.2 Global Orally Disintegrating Tablet Revenue by Type (2021–2032)
4.2.1 Global Orally Disintegrating Tablet Revenue by Type (2021–2026)
4.2.2 Global Orally Disintegrating Tablet Revenue by Type (2027–2032)
4.2.3 Global Orally Disintegrating Tablet Revenue Market Share by Type (2021–2032)
4.3 Global Orally Disintegrating Tablet Price by Type (2021–2032)
5 Segment by Application
5.1 Global Orally Disintegrating Tablet Sales by Application (2021–2032)
5.1.1 Global Orally Disintegrating Tablet Sales by Application (2021–2026)
5.1.2 Global Orally Disintegrating Tablet Sales by Application (2027–2032)
5.1.3 Global Orally Disintegrating Tablet Sales Market Share by Application (2021–2032)
5.2 Global Orally Disintegrating Tablet Revenue by Application (2021–2032)
5.2.1 Global Orally Disintegrating Tablet Revenue by Application (2021–2026)
5.2.2 Global Orally Disintegrating Tablet Revenue by Application (2027–2032)
5.2.3 Global Orally Disintegrating Tablet Revenue Market Share by Application (2021–2032)
5.3 Global Orally Disintegrating Tablet Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Company Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Orally Disintegrating Tablet Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Teva Orally Disintegrating Tablet Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Orally Disintegrating Tablet Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck Orally Disintegrating Tablet Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Viatris
6.3.1 Viatris Company Information
6.3.2 Viatris Description and Business Overview
6.3.3 Viatris Orally Disintegrating Tablet Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Viatris Orally Disintegrating Tablet Product Portfolio
6.3.5 Viatris Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Orally Disintegrating Tablet Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Pfizer Orally Disintegrating Tablet Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Johnson and Johnson
6.5.1 Johnson and Johnson Company Information
6.5.2 Johnson and Johnson Description and Business Overview
6.5.3 Johnson and Johnson Orally Disintegrating Tablet Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Johnson and Johnson Orally Disintegrating Tablet Product Portfolio
6.5.5 Johnson and Johnson Recent Developments/Updates
6.6 GSK
6.6.1 GSK Company Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Orally Disintegrating Tablet Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 GSK Orally Disintegrating Tablet Product Portfolio
6.6.5 GSK Recent Developments/Updates
6.7 Otsuka
6.7.1 Otsuka Company Information
6.7.2 Otsuka Description and Business Overview
6.7.3 Otsuka Orally Disintegrating Tablet Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Otsuka Orally Disintegrating Tablet Product Portfolio
6.7.5 Otsuka Recent Developments/Updates
6.8 Eli Lilly and Company
6.8.1 Eli Lilly and Company Company Information
6.8.2 Eli Lilly and Company Description and Business Overview
6.8.3 Eli Lilly and Company Orally Disintegrating Tablet Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Eli Lilly and Company Orally Disintegrating Tablet Product Portfolio
6.8.5 Eli Lilly and Company Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Company Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Orally Disintegrating Tablet Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 AstraZeneca Orally Disintegrating Tablet Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Company Information
6.10.2 Bristol-Myers Squibb Description and Business Overview
6.10.3 Bristol-Myers Squibb Orally Disintegrating Tablet Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Bristol-Myers Squibb Orally Disintegrating Tablet Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments/Updates
6.11 Conquer
6.11.1 Conquer Company Information
6.11.2 Conquer Description and Business Overview
6.11.3 Conquer Orally Disintegrating Tablet Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Conquer Orally Disintegrating Tablet Product Portfolio
6.11.5 Conquer Recent Developments/Updates
6.12 Eisai
6.12.1 Eisai Company Information
6.12.2 Eisai Description and Business Overview
6.12.3 Eisai Orally Disintegrating Tablet Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Eisai Orally Disintegrating Tablet Product Portfolio
6.12.5 Eisai Recent Developments/Updates
6.13 Cipla
6.13.1 Cipla Company Information
6.13.2 Cipla Description and Business Overview
6.13.3 Cipla Orally Disintegrating Tablet Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Cipla Orally Disintegrating Tablet Product Portfolio
6.13.5 Cipla Recent Developments/Updates
6.14 Zydus Lifesciences
6.14.1 Zydus Lifesciences Company Information
6.14.2 Zydus Lifesciences Description and Business Overview
6.14.3 Zydus Lifesciences Orally Disintegrating Tablet Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Zydus Lifesciences Orally Disintegrating Tablet Product Portfolio
6.14.5 Zydus Lifesciences Recent Developments/Updates
6.15 Qilu Pharma
6.15.1 Qilu Pharma Company Information
6.15.2 Qilu Pharma Description and Business Overview
6.15.3 Qilu Pharma Orally Disintegrating Tablet Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Qilu Pharma Orally Disintegrating Tablet Product Portfolio
6.15.5 Qilu Pharma Recent Developments/Updates
6.16 Hisun Pharm
6.16.1 Hisun Pharm Company Information
6.16.2 Hisun Pharm Description and Business Overview
6.16.3 Hisun Pharm Orally Disintegrating Tablet Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Hisun Pharm Orally Disintegrating Tablet Product Portfolio
6.16.5 Hisun Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Orally Disintegrating Tablet Industry Chain Analysis
7.2 Orally Disintegrating Tablet Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Orally Disintegrating Tablet Production Mode & Process Analysis
7.4 Orally Disintegrating Tablet Sales and Marketing
7.4.1 Orally Disintegrating Tablet Sales Channels
7.4.2 Orally Disintegrating Tablet Distributors
7.5 Orally Disintegrating Tablet Customer Analysis
8 Orally Disintegrating Tablet Market Dynamics
8.1 Orally Disintegrating Tablet Industry Trends
8.2 Orally Disintegrating Tablet Market Drivers
8.3 Orally Disintegrating Tablet Market Challenges
8.4 Orally Disintegrating Tablet Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Orally Disintegrating Tablet Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Orally Disintegrating Tablet Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Orally Disintegrating Tablet Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Orally Disintegrating Tablet Sales (M Units) of Key Manufacturers (2021–2026)
 Table 5. Global Orally Disintegrating Tablet Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Orally Disintegrating Tablet Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Orally Disintegrating Tablet Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Orally Disintegrating Tablet Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Orally Disintegrating Tablet, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Orally Disintegrating Tablet, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Orally Disintegrating Tablet, Product Types and Applications
 Table 12. Global Key Manufacturers of Orally Disintegrating Tablet, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Orally Disintegrating Tablet Companies by Tier (Tier 1, Tier 2, Tier 3), based on Orally Disintegrating Tablet Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Orally Disintegrating Tablet Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Orally Disintegrating Tablet Sales by Region (M Units), 2021–2026
 Table 18. Global Orally Disintegrating Tablet Sales Market Share by Region (2021–2026)
 Table 19. Global Orally Disintegrating Tablet Sales by Region (M Units), 2027–2032
 Table 20. Global Orally Disintegrating Tablet Sales Market Share by Region (2027–2032)
 Table 21. Global Orally Disintegrating Tablet Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Orally Disintegrating Tablet Revenue Market Share by Region (2021–2026)
 Table 23. Global Orally Disintegrating Tablet Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Orally Disintegrating Tablet Revenue Market Share by Region (2027–2032)
 Table 25. North America Orally Disintegrating Tablet Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Orally Disintegrating Tablet Sales by Country (M Units), 2021–2026
 Table 27. North America Orally Disintegrating Tablet Sales by Country (M Units), 2027–2032
 Table 28. North America Orally Disintegrating Tablet Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Orally Disintegrating Tablet Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Orally Disintegrating Tablet Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Orally Disintegrating Tablet Sales by Country (M Units), 2021–2026
 Table 32. Europe Orally Disintegrating Tablet Sales by Country (M Units), 2027–2032
 Table 33. Europe Orally Disintegrating Tablet Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Orally Disintegrating Tablet Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Orally Disintegrating Tablet Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Orally Disintegrating Tablet Sales by Region (M Units), 2021–2026
 Table 37. Asia Pacific Orally Disintegrating Tablet Sales by Region (M Units), 2027–2032
 Table 38. Asia Pacific Orally Disintegrating Tablet Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Orally Disintegrating Tablet Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Orally Disintegrating Tablet Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Orally Disintegrating Tablet Sales by Country (M Units), 2021–2026
 Table 42. Latin America Orally Disintegrating Tablet Sales by Country (M Units), 2027–2032
 Table 43. Latin America Orally Disintegrating Tablet Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Orally Disintegrating Tablet Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Orally Disintegrating Tablet Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Orally Disintegrating Tablet Sales by Country (M Units), 2021–2026
 Table 47. Middle East and Africa Orally Disintegrating Tablet Sales by Country (M Units), 2027–2032
 Table 48. Middle East and Africa Orally Disintegrating Tablet Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Orally Disintegrating Tablet Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Orally Disintegrating Tablet Sales (M Units) by Type (2021–2026)
 Table 51. Global Orally Disintegrating Tablet Sales (M Units) by Type (2027–2032)
 Table 52. Global Orally Disintegrating Tablet Sales Market Share by Type (2021–2026)
 Table 53. Global Orally Disintegrating Tablet Sales Market Share by Type (2027–2032)
 Table 54. Global Orally Disintegrating Tablet Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Orally Disintegrating Tablet Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Orally Disintegrating Tablet Revenue Market Share by Type (2021–2026)
 Table 57. Global Orally Disintegrating Tablet Revenue Market Share by Type (2027–2032)
 Table 58. Global Orally Disintegrating Tablet Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Orally Disintegrating Tablet Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Orally Disintegrating Tablet Sales (M Units) by Application (2021–2026)
 Table 61. Global Orally Disintegrating Tablet Sales (M Units) by Application (2027–2032)
 Table 62. Global Orally Disintegrating Tablet Sales Market Share by Application (2021–2026)
 Table 63. Global Orally Disintegrating Tablet Sales Market Share by Application (2027–2032)
 Table 64. Global Orally Disintegrating Tablet Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Orally Disintegrating Tablet Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Orally Disintegrating Tablet Revenue Market Share by Application (2021–2026)
 Table 67. Global Orally Disintegrating Tablet Revenue Market Share by Application (2027–2032)
 Table 68. Global Orally Disintegrating Tablet Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Orally Disintegrating Tablet Price (US$/Unit) by Application (2027–2032)
 Table 70. Teva Company Information
 Table 71. Teva Description and Business Overview
 Table 72. Teva Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Teva Orally Disintegrating Tablet Product
 Table 74. Teva Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Merck Orally Disintegrating Tablet Product
 Table 79. Merck Recent Developments/Updates
 Table 80. Viatris Company Information
 Table 81. Viatris Description and Business Overview
 Table 82. Viatris Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Viatris Orally Disintegrating Tablet Product
 Table 84. Viatris Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Pfizer Orally Disintegrating Tablet Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. Johnson and Johnson Company Information
 Table 91. Johnson and Johnson Description and Business Overview
 Table 92. Johnson and Johnson Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Johnson and Johnson Orally Disintegrating Tablet Product
 Table 94. Johnson and Johnson Recent Developments/Updates
 Table 95. GSK Company Information
 Table 96. GSK Description and Business Overview
 Table 97. GSK Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. GSK Orally Disintegrating Tablet Product
 Table 99. GSK Recent Developments/Updates
 Table 100. Otsuka Company Information
 Table 101. Otsuka Description and Business Overview
 Table 102. Otsuka Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Otsuka Orally Disintegrating Tablet Product
 Table 104. Otsuka Recent Developments/Updates
 Table 105. Eli Lilly and Company Company Information
 Table 106. Eli Lilly and Company Description and Business Overview
 Table 107. Eli Lilly and Company Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Eli Lilly and Company Orally Disintegrating Tablet Product
 Table 109. Eli Lilly and Company Recent Developments/Updates
 Table 110. AstraZeneca Company Information
 Table 111. AstraZeneca Description and Business Overview
 Table 112. AstraZeneca Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. AstraZeneca Orally Disintegrating Tablet Product
 Table 114. AstraZeneca Recent Developments/Updates
 Table 115. Bristol-Myers Squibb Company Information
 Table 116. Bristol-Myers Squibb Description and Business Overview
 Table 117. Bristol-Myers Squibb Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Bristol-Myers Squibb Orally Disintegrating Tablet Product
 Table 119. Bristol-Myers Squibb Recent Developments/Updates
 Table 120. Conquer Company Information
 Table 121. Conquer Description and Business Overview
 Table 122. Conquer Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Conquer Orally Disintegrating Tablet Product
 Table 124. Conquer Recent Developments/Updates
 Table 125. Eisai Company Information
 Table 126. Eisai Description and Business Overview
 Table 127. Eisai Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Eisai Orally Disintegrating Tablet Product
 Table 129. Eisai Recent Developments/Updates
 Table 130. Cipla Company Information
 Table 131. Cipla Description and Business Overview
 Table 132. Cipla Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Cipla Orally Disintegrating Tablet Product
 Table 134. Cipla Recent Developments/Updates
 Table 135. Zydus Lifesciences Company Information
 Table 136. Zydus Lifesciences Description and Business Overview
 Table 137. Zydus Lifesciences Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Zydus Lifesciences Orally Disintegrating Tablet Product
 Table 139. Zydus Lifesciences Recent Developments/Updates
 Table 140. Qilu Pharma Company Information
 Table 141. Qilu Pharma Description and Business Overview
 Table 142. Qilu Pharma Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Qilu Pharma Orally Disintegrating Tablet Product
 Table 144. Qilu Pharma Recent Developments/Updates
 Table 145. Hisun Pharm Company Information
 Table 146. Hisun Pharm Description and Business Overview
 Table 147. Hisun Pharm Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Hisun Pharm Orally Disintegrating Tablet Product
 Table 149. Hisun Pharm Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Orally Disintegrating Tablet Distributors List
 Table 153. Orally Disintegrating Tablet Customers List
 Table 154. Orally Disintegrating Tablet Market Trends
 Table 155. Orally Disintegrating Tablet Market Drivers
 Table 156. Orally Disintegrating Tablet Market Challenges
 Table 157. Orally Disintegrating Tablet Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Orally Disintegrating Tablet
 Figure 2. Global Orally Disintegrating Tablet Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Orally Disintegrating Tablet Market Share by Type: 2025 & 2032
 Figure 4. Anti-Psychotics Drug Product Picture
 Figure 5. Anti-Epileptics Drug Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Orally Disintegrating Tablet Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Orally Disintegrating Tablet Market Share by Application: 2025 & 2032
 Figure 9. CNS Diseases
 Figure 10. Gastrointestinal Diseases
 Figure 11. CVS Diseases
 Figure 12. Others
 Figure 13. Global Orally Disintegrating Tablet Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Orally Disintegrating Tablet Market Size (US$ Million), 2021–2032
 Figure 15. Global Orally Disintegrating Tablet Sales (M Units), 2021–2032
 Figure 16. Global Orally Disintegrating Tablet Average Price (US$/Unit), 2021–2032
 Figure 17. Orally Disintegrating Tablet Report Years Considered
 Figure 18. Orally Disintegrating Tablet Sales Share by Manufacturers in 2025
 Figure 19. Global Orally Disintegrating Tablet Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Orally Disintegrating Tablet Players: Market Share by Revenue in Orally Disintegrating Tablet in 2025
 Figure 21. Orally Disintegrating Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Orally Disintegrating Tablet Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Orally Disintegrating Tablet Sales Market Share by Country (2021–2032)
 Figure 24. North America Orally Disintegrating Tablet Revenue Market Share by Country (2021–2032)
 Figure 25. United States Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Orally Disintegrating Tablet Sales Market Share by Country (2021–2032)
 Figure 28. Europe Orally Disintegrating Tablet Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Orally Disintegrating Tablet Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Orally Disintegrating Tablet Revenue Market Share by Region (2021–2032)
 Figure 36. China Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Taiwan Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Indonesia Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Thailand Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Malaysia Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Philippines Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Latin America Orally Disintegrating Tablet Sales Market Share by Country (2021–2032)
 Figure 47. Latin America Orally Disintegrating Tablet Revenue Market Share by Country (2021–2032)
 Figure 48. Mexico Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Brazil Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Argentina Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Middle East and Africa Orally Disintegrating Tablet Sales Market Share by Country (2021–2032)
 Figure 52. Middle East and Africa Orally Disintegrating Tablet Revenue Market Share by Country (2021–2032)
 Figure 53. Turkey Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Saudi Arabia Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. UAE Orally Disintegrating Tablet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Global Sales Market Share of Orally Disintegrating Tablet by Type (2021–2032)
 Figure 57. Global Revenue Market Share of Orally Disintegrating Tablet by Type (2021–2032)
 Figure 58. Global Orally Disintegrating Tablet Price (US$/Unit) by Type (2021–2032)
 Figure 59. Global Sales Market Share of Orally Disintegrating Tablet by Application (2021–2032)
 Figure 60. Global Revenue Market Share of Orally Disintegrating Tablet by Application (2021–2032)
 Figure 61. Global Orally Disintegrating Tablet Price (US$/Unit) by Application (2021–2032)
 Figure 62. Orally Disintegrating Tablet Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners